In addition, an in vivo study reveals that versican could stimulate mesenchymal to epithelial transition (MET) of metastatic tumor cells by attenuating phospho-Smad 2 levels, which result in elevated cell proliferation and accelerated metastases [38]. Here, VCAN is linked to neoplasm.